Alkermes (ALKS) Revenue (2010 - 2026)
Alkermes (ALKS) posted quarterly Revenue of $496.0 million for Q2 2026, up 26.97% year-over-year from $390.7 million in Q2 2025, and up 26.24% quarter-over-quarter from $392.9 million in Q1 2026.
Alkermes (ALKS) Revenue (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Revenue for 17 consecutive years, with $496.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Revenue rose 26.97% year-over-year to $496.0 million; the TTM figure through Jun 2026 stood at $1.7 billion (up 10.79% YoY), while the FY2025 annual figure was $1.5 billion, down 5.25% from the prior year.
- Revenue climbed to $496.0 million in Q2 2026 per ALKS's latest filing, from $392.9 million in the prior quarter.
- Across five years, Revenue topped out at $617.4 million in Q2 2023 and bottomed at $3.2 million in Q2 2022.
- Historically, Revenue has averaged $343.1 million across 5 years, with a median of $379.5 million in 2023.
- Annual changes were most pronounced in 2022 — Revenue plunged 98.95% — and 2023, when it jumped 19193.66%.
- Alkermes' Revenue stood at $304.7 million in 2022, then rose by 23.89% to $377.5 million in 2023, then grew by 13.91% to $430.0 million in 2024, then fell by 10.57% to $384.5 million in 2025, then grew by 28.99% to $496.0 million in 2026.
- Business Quant data shows ALKS's Revenue at $496.0 million in Q2 2026, $392.9 million in Q1 2026, and $384.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 496.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 496.01 Mn |
| Mar 31, 2026 | 392.91 Mn |
| Dec 31, 2025 | 384.55 Mn |
| Sep 30, 2025 | 394.19 Mn |
| Jun 30, 2025 | 390.66 Mn |
| Mar 31, 2025 | 306.51 Mn |
| Dec 31, 2024 | 429.99 Mn |
| Sep 30, 2024 | 378.14 Mn |
| Jun 30, 2024 | 399.13 Mn |
| Mar 31, 2024 | 350.37 Mn |
| Dec 31, 2023 | 377.48 Mn |
| Sep 30, 2023 | 380.94 Mn |
| Jun 30, 2023 | 617.40 Mn |
| Mar 31, 2023 | 287.60 Mn |
| Dec 31, 2022 | 304.67 Mn |
| Sep 30, 2022 | 3.20 Mn |
| Jun 30, 2022 | 3.20 Mn |
| Mar 31, 2022 | 278.55 Mn |
| Dec 31, 2021 | 324.46 Mn |
| Sep 30, 2021 | 294.14 Mn |